Owkin
@owkin.bsky.social
We use artificial intelligence to find the right treatment for every patient.
Learn more at owkin.com #techbio
Learn more at owkin.com #techbio
Pinned
Owkin
@owkin.bsky.social
· Mar 6
💥 Owkin K Navigator launches on the 6th of May. Our free-to-use agentic AI co-pilot for researchers across the world, to enhance the productivity of biological research and drive breakthrough discoveries.
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
Published in Scientific Reports: SarcNet uses federated AI to forecast metastatic relapse in STS, achieving 0.797 AUC. Dive deeper: www.nature.com/articles/s41...
November 7, 2025 at 9:42 AM
Published in Scientific Reports: SarcNet uses federated AI to forecast metastatic relapse in STS, achieving 0.797 AUC. Dive deeper: www.nature.com/articles/s41...
We’re releasing CytoSyn, our new diffusion model for synthetic histopathology image generation. REPA-E architecture. H0-mini conditioning.
Model: huggingface.co/Owkin-Biopti...
Supporting article: www.owkin.com/blogs-case-s...
Model: huggingface.co/Owkin-Biopti...
Supporting article: www.owkin.com/blogs-case-s...
November 5, 2025 at 10:30 AM
We’re releasing CytoSyn, our new diffusion model for synthetic histopathology image generation. REPA-E architecture. H0-mini conditioning.
Model: huggingface.co/Owkin-Biopti...
Supporting article: www.owkin.com/blogs-case-s...
Model: huggingface.co/Owkin-Biopti...
Supporting article: www.owkin.com/blogs-case-s...
Discover OKN4395 at #SITC2025—Poster #1169. A triple inhibitor overcoming tumor immunosuppression by targeting EP2, EP4, DP1.
Learn more about OKN4395 at epkin.ai
Learn more about OKN4395 at epkin.ai
November 4, 2025 at 9:37 AM
Discover OKN4395 at #SITC2025—Poster #1169. A triple inhibitor overcoming tumor immunosuppression by targeting EP2, EP4, DP1.
Learn more about OKN4395 at epkin.ai
Learn more about OKN4395 at epkin.ai
Our new multimodal ML models achieve high accuracy in predicting iCCA outcomes (c-index 0.70). This collaborative study with @mskcancercenter.bsky.social enhances understanding of the disease and may guide treatment selection.
Check out the paper: www.sciencedirect.com/science/arti...
Check out the paper: www.sciencedirect.com/science/arti...
October 30, 2025 at 3:49 PM
Our new multimodal ML models achieve high accuracy in predicting iCCA outcomes (c-index 0.70). This collaborative study with @mskcancercenter.bsky.social enhances understanding of the disease and may guide treatment selection.
Check out the paper: www.sciencedirect.com/science/arti...
Check out the paper: www.sciencedirect.com/science/arti...
We dived into cancer cell interactions with COMPOTES. Using MOSAIC data, we uncovered 45 programs across major cancers, shedding light on immune dynamics and therapeutic paths.
Pre-print at: doi.org/10.1101/2025...
Pre-print at: doi.org/10.1101/2025...
October 28, 2025 at 2:39 PM
We dived into cancer cell interactions with COMPOTES. Using MOSAIC data, we uncovered 45 programs across major cancers, shedding light on immune dynamics and therapeutic paths.
Pre-print at: doi.org/10.1101/2025...
Pre-print at: doi.org/10.1101/2025...
We used ML & multimodal data to find glioblastoma biomarkers linked to long survival. Our model (AUC 0.85), trained on @ap-hp.bsky.social data, reveals tissue regions predicting survival. Model interpretation & biological insights from MOSAIC’s GBM cohort.
Pre-print: www.biorxiv.org/content/10.1...
Pre-print: www.biorxiv.org/content/10.1...
October 23, 2025 at 2:25 PM
We used ML & multimodal data to find glioblastoma biomarkers linked to long survival. Our model (AUC 0.85), trained on @ap-hp.bsky.social data, reveals tissue regions predicting survival. Model interpretation & biological insights from MOSAIC’s GBM cohort.
Pre-print: www.biorxiv.org/content/10.1...
Pre-print: www.biorxiv.org/content/10.1...
📢 New on bioRxiv: We developed SpaMIL, a novel Multiple Instance Learning (MIL) framework for predicting patient-level outcomes from spatial transcriptomics data.
Read the preprint: www.biorxiv.org/content/10.1...
Read the preprint: www.biorxiv.org/content/10.1...
October 22, 2025 at 12:30 PM
📢 New on bioRxiv: We developed SpaMIL, a novel Multiple Instance Learning (MIL) framework for predicting patient-level outcomes from spatial transcriptomics data.
Read the preprint: www.biorxiv.org/content/10.1...
Read the preprint: www.biorxiv.org/content/10.1...
K Navigator launches on May 6th - introducing the scientific literature tool, K-literature, tailored to scientific research, featuring:
📑 26.5+ million papers
🧠 Natural language input
👥 Hallucination limitation
K Navigator is free to use for academic researchers.
www.owkin.com/k-os/owkin-k...
📑 26.5+ million papers
🧠 Natural language input
👥 Hallucination limitation
K Navigator is free to use for academic researchers.
www.owkin.com/k-os/owkin-k...
April 2, 2025 at 8:22 AM
K Navigator launches on May 6th - introducing the scientific literature tool, K-literature, tailored to scientific research, featuring:
📑 26.5+ million papers
🧠 Natural language input
👥 Hallucination limitation
K Navigator is free to use for academic researchers.
www.owkin.com/k-os/owkin-k...
📑 26.5+ million papers
🧠 Natural language input
👥 Hallucination limitation
K Navigator is free to use for academic researchers.
www.owkin.com/k-os/owkin-k...
🕹️ How fast can you reach K? Play the game as we get ready to launch K Navigator, a free agentic AI co-pilot boosting the productivity of biology research and breakthroughs across the world.
Try it now:
Google Play → play.google.com/store/apps/d...
App Store → apps.apple.com/fr/app/first...
Try it now:
Google Play → play.google.com/store/apps/d...
App Store → apps.apple.com/fr/app/first...
March 13, 2025 at 10:53 AM
🕹️ How fast can you reach K? Play the game as we get ready to launch K Navigator, a free agentic AI co-pilot boosting the productivity of biology research and breakthroughs across the world.
Try it now:
Google Play → play.google.com/store/apps/d...
App Store → apps.apple.com/fr/app/first...
Try it now:
Google Play → play.google.com/store/apps/d...
App Store → apps.apple.com/fr/app/first...
Excited to share our latest research on a novel approach for controlling the sensitivity of whole-slide image classification models in digital pathology, using the TSM (Tile Score Matching) method.
Read the full pre-print: arxiv.org/abs/2502.20144
Read the full pre-print: arxiv.org/abs/2502.20144
March 13, 2025 at 9:04 AM
Excited to share our latest research on a novel approach for controlling the sensitivity of whole-slide image classification models in digital pathology, using the TSM (Tile Score Matching) method.
Read the full pre-print: arxiv.org/abs/2502.20144
Read the full pre-print: arxiv.org/abs/2502.20144
💥 Owkin K Navigator launches on the 6th of May. Our free-to-use agentic AI co-pilot for researchers across the world, to enhance the productivity of biological research and drive breakthrough discoveries.
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
March 6, 2025 at 12:38 PM
💥 Owkin K Navigator launches on the 6th of May. Our free-to-use agentic AI co-pilot for researchers across the world, to enhance the productivity of biological research and drive breakthrough discoveries.
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
Kountdown to K begins now. Sign up here → www.owkin.com/k-os/owkin-k
We're launching a comprehensive multimodal patient data discovery program with 20 leading healthcare institutions across France, Spain, Germany, Italy, the US, the UK, and Israel to accelerate medical research by breaking down data silos.
Read more at → www.owkin.com/newsfeed/owk...
Read more at → www.owkin.com/newsfeed/owk...
February 27, 2025 at 12:06 PM
We're launching a comprehensive multimodal patient data discovery program with 20 leading healthcare institutions across France, Spain, Germany, Italy, the US, the UK, and Israel to accelerate medical research by breaking down data silos.
Read more at → www.owkin.com/newsfeed/owk...
Read more at → www.owkin.com/newsfeed/owk...
Reposted by Owkin
Join us for a webinar, co-hosted with @owkin.bsky.social, on "Harnessing spatial biology & AI to develop targeted therapeutic strategies." Learn how Owkin is using spatial & AI to optimize development of antibody-drug conjugate strategies & generate novel hypotheses: bit.ly/4jVbQZr
February 18, 2025 at 8:00 PM
Join us for a webinar, co-hosted with @owkin.bsky.social, on "Harnessing spatial biology & AI to develop targeted therapeutic strategies." Learn how Owkin is using spatial & AI to optimize development of antibody-drug conjugate strategies & generate novel hypotheses: bit.ly/4jVbQZr
After an eventful #AIActionSummit, our SVP, Head of Public Affairs & Impact Yedidia Levy-Zauberman unpacks Owkin’s key moments in our latest blog - from a high-impact glioblastoma hackathon to recognition by President Emmanuel Macron.
📕 Read the blog → www.owkin.com/blogs-case-s...
📕 Read the blog → www.owkin.com/blogs-case-s...
Driving innovation in AI for healthcare: Owkin at the AI Action Summit
www.owkin.com
February 14, 2025 at 10:55 AM
After an eventful #AIActionSummit, our SVP, Head of Public Affairs & Impact Yedidia Levy-Zauberman unpacks Owkin’s key moments in our latest blog - from a high-impact glioblastoma hackathon to recognition by President Emmanuel Macron.
📕 Read the blog → www.owkin.com/blogs-case-s...
📕 Read the blog → www.owkin.com/blogs-case-s...
Reposted by Owkin
A comprehensive evaluation of histopathology foundation models for ovarian cancer subtype classification www.nature.com/articles/s41... @owkin.bsky.social
A comprehensive evaluation of histopathology foundation models for ovarian cancer subtype classification - npj Precision Oncology
npj Precision Oncology - A comprehensive evaluation of histopathology foundation models for ovarian cancer subtype classification
www.nature.com
February 8, 2025 at 11:36 AM
A comprehensive evaluation of histopathology foundation models for ovarian cancer subtype classification www.nature.com/articles/s41... @owkin.bsky.social
Can AI help Pharma speed up drug development? World Street Journal features our CEO Thomas Clozel alongside Aviv Regev from Genentech, AstraZeneca's Chief Data Scientist Jim Weatherall, and GSK's Senior Director of ML and AI Patrick Schwab.
📰 Read the WSJ article → www.wsj.com/tech/ai/phar...
📰 Read the WSJ article → www.wsj.com/tech/ai/phar...
Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s potential.
www.wsj.com
February 11, 2025 at 9:20 AM
Can AI help Pharma speed up drug development? World Street Journal features our CEO Thomas Clozel alongside Aviv Regev from Genentech, AstraZeneca's Chief Data Scientist Jim Weatherall, and GSK's Senior Director of ML and AI Patrick Schwab.
📰 Read the WSJ article → www.wsj.com/tech/ai/phar...
📰 Read the WSJ article → www.wsj.com/tech/ai/phar...
Owkin in the news 👀 Emmanuelle Macron references Owkin’s work, speaking on France’s AI boom 💥 for the #AIActionSummit.
Les Echos dives deeper into Owkin’s mission to redefine healthcare through AI: “AI in healthcare - France’s trump card”.
Read more here → www.lesechos.fr/start-up/eco...
Les Echos dives deeper into Owkin’s mission to redefine healthcare through AI: “AI in healthcare - France’s trump card”.
Read more here → www.lesechos.fr/start-up/eco...
February 10, 2025 at 2:30 PM
Owkin in the news 👀 Emmanuelle Macron references Owkin’s work, speaking on France’s AI boom 💥 for the #AIActionSummit.
Les Echos dives deeper into Owkin’s mission to redefine healthcare through AI: “AI in healthcare - France’s trump card”.
Read more here → www.lesechos.fr/start-up/eco...
Les Echos dives deeper into Owkin’s mission to redefine healthcare through AI: “AI in healthcare - France’s trump card”.
Read more here → www.lesechos.fr/start-up/eco...
Le Figaro features our CEO, Thomas Clozel, as one of the top seven French ⭐️s in the AI industry alongside @yann-lecun.bsky.social, Jérôme Pesenti - Owkin board member - and Luc Julia, creator of Apple’s Siri. 👀
Read the article → www.lefigaro.fr/secteur/high...
Read the article → www.lefigaro.fr/secteur/high...
Yann Le Cun, Joëlle Barral, Arthur Mensch... Ces sept grandes figures françaises de l’intelligence artificielle
PORTRAITS - Discrètes, ces personnalités façonnent pourtant le monde de demain. Beaucoup d’entre elles ont fait leurs armes au sein des Gafam avant, parfois, de déployer leurs solutions en France. Le ...
www.lefigaro.fr
February 10, 2025 at 1:15 PM
Le Figaro features our CEO, Thomas Clozel, as one of the top seven French ⭐️s in the AI industry alongside @yann-lecun.bsky.social, Jérôme Pesenti - Owkin board member - and Luc Julia, creator of Apple’s Siri. 👀
Read the article → www.lefigaro.fr/secteur/high...
Read the article → www.lefigaro.fr/secteur/high...
📢 4 hours in, 100s of lines of code already written, our Glioblastoma moonshot hackathon is off with a bang. 💥
Learn more at: www.owkin.com/connect/glio...
#GBM #Hackathon
Learn more at: www.owkin.com/connect/glio...
#GBM #Hackathon
February 3, 2025 at 2:54 PM
📢 4 hours in, 100s of lines of code already written, our Glioblastoma moonshot hackathon is off with a bang. 💥
Learn more at: www.owkin.com/connect/glio...
#GBM #Hackathon
Learn more at: www.owkin.com/connect/glio...
#GBM #Hackathon
3 days to go until 100 experts meet at Palais Brongniart, Paris, for our AI Moonshot Hackathon in Glioblastoma Research!
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
January 31, 2025 at 2:24 PM
3 days to go until 100 experts meet at Palais Brongniart, Paris, for our AI Moonshot Hackathon in Glioblastoma Research!
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
Sponsored by Servier and Owkin, with support from AWS, 10x Genomics, Bioptimus, and La Place Fintech.
Learn more: www.owkin.com/connect/glio...
#gbm #neuroskyence #spatialomics
We’re excited to announce the first patient has been dosed in our Phase 1 clinical trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for solid tumors.
Learn more in STAT’s latest interview with Andrew Pierce, Owkin’s SVP Discovery & Development: www.statnews.com/2025/01/30/o...
Learn more in STAT’s latest interview with Andrew Pierce, Owkin’s SVP Discovery & Development: www.statnews.com/2025/01/30/o...
How AI helps drug developers skirt pharma’s ‘dirty little secret’
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.
www.statnews.com
January 30, 2025 at 4:38 PM
We’re excited to announce the first patient has been dosed in our Phase 1 clinical trial of OKN4395, a first-in-class EP2/EP4/DP1 triple inhibitor for solid tumors.
Learn more in STAT’s latest interview with Andrew Pierce, Owkin’s SVP Discovery & Development: www.statnews.com/2025/01/30/o...
Learn more in STAT’s latest interview with Andrew Pierce, Owkin’s SVP Discovery & Development: www.statnews.com/2025/01/30/o...
Check out our explainer video to see how our new AI model predicts YAP1/TEAD activity directly from routine H&E-stained histology slides.
Watch the video: vimeo.com/1035641635?s...
#pathsky #aisky #medai
Watch the video: vimeo.com/1035641635?s...
#pathsky #aisky #medai
iScience | TEAD explainer
Discover how AI and multimodal data predict YAP1-TEAD activity from histology slides, aiding cancer treatment. Learn about biomarkers, TEAD inhibitors, and clinical…
vimeo.com
January 29, 2025 at 10:07 AM
Check out our explainer video to see how our new AI model predicts YAP1/TEAD activity directly from routine H&E-stained histology slides.
Watch the video: vimeo.com/1035641635?s...
#pathsky #aisky #medai
Watch the video: vimeo.com/1035641635?s...
#pathsky #aisky #medai